COVID-19

Pharmacy Times® interviewed Amanda Epp, MBA, CEO of ScriptDrop, on how the COVID-19 pandemic has affected consumer behavior trends in the switch to digital prescription fulfillment.

The rising global death toll, in addition to the economic consequences of the pandemic, have led many calls to mandate a COVID-19 vaccination if and when a vaccine is approved.

The transmission of COVID-19 depends almost entirely on human behavior, meaning temperature and humidity do not play a significant role, study suggests.

Investigational COVID-19 antibody was authorized in a 700 mg dose for adults and pediatric patients 12 years and older and should be administered as soon as possible after diagnosis and within 10 days of symptom onset.

Pharmacy Times® interviewed Petros Grivas, MD, PhD, associate professor at the University of Washington and Fred Hutchinson Cancer Research Center and a medical oncologist at Seattle Cancer Care Alliance, on the work of the COVID-19 and Cancer Consortium.

A new study suggests that COVID-19 antibodies remain in the body for up to 5 months.

Even in a relatively asymptomatic case of COVID-19, it is possible that the virus could have fostered retrograde reactivation of the varicella-zoster virus.

Pfizer and BioNTech plan for submission to the FDA for an Emergency Use Authorization soon after the required safety milestone is achieved in mid-November for a promising novel COVID-19 vaccine candidate.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.

Novel COVID-19 vaccine uses nanoparticles instead of targeting the spike protein.

The pharmacist plays a critical role in supporting the care plan developed between the patient and the physician.

Pharmacy Times® interviewed Rich Morino, senior director of health care solutions at LexisNexis, on how using social determinants of health in tandem with clinical data can benefit pharmacies.

By simulating inhalation, exhalation, coughs, and sneezes in the laboratory, the researchers discovered that non-woven fabrics used in most masks work well to demonstrate the concept.

Investigators demonstrated that protection from COVID-19 transmission increases with physical distancing in an approximately linear proportion.

Questions remain whether recovered COVID-19 patients who test positive are still contagious.

Further research is essential in order to determine the relationship between diabetes and COVID-19 and what impact glucose-lowering drugs may have.

Research suggests global access to COVID-19 vaccines is best for both global health and finances.

The greater effect on population-wide alcohol use could be tied to the effects of the COVID-19 pandemic, including widespread social disruption and isolation, limited social support and access to medical care, and negative domestic and global economic impacts.

Pharmacy Times® interviewed Amanda Epp, MBA, the CEO of ScriptDrop, on how granting provider status to pharmacists can allow them to better support the health care system in the fight against COVID-19.

Study shows large reductions in visits to essential stores during the pandemic, such as pharmacies, but found essentially no reduction in non-essential visits to parks and other outdoor spots.

Researchers from 2 independent studies have found that SARS-CoV-2 may be more capable of infecting human cells due to the virus’ spike protein recognizing and binding to neuropilin-1.

Pharmacy students answered the question “Have you been able to build a professional pharmacy network during the pandemic?” The video is one part in the Pharmacy Times Student Café series.

Pharmacy Times® interviewed Ned Milenkovich, PharmD, JD, principal and co-chair of the Health Care Law practice group at Much Shelist, on how federal and state law may affect vaccine administration in accordance with recent HHS declarations.

Researchers suggest several modifications in the way health professionals manage patients with obesity during the COVID-19 pandemic.

Using several sources of data, researchers at Linköping University in Sweden developed a new method to predict flu epidemics.